Iovance Biotherapeutics Inc (IOVA) — Cash Flow Quality Index
Latest as of June 2013:
1.92x
Iovance Biotherapeutics Inc (IOVA) has a Cash Flow Quality Index of 1.92x as of June 2013. Operating cash flow of $6.65 Million exceeds net income of $3.47 Million, indicating high earnings quality where cash backs reported profits. Explore IOVA long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
1.92x
Operating CF / Net Income
Operating Cash Flow
$6.65 Million
USD
Net Income
$3.47 Million
USD
Data as of
Jun 2013
Most recent filing
Annual Cash Flow Quality Index for Iovance Biotherapeutics Inc (None–None)
Year-by-year earnings quality comparison for Iovance Biotherapeutics Inc. For live market cap and the full company financial profile, see IOVA stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.